HLS
HEALIUS ORDINARYHealius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
HLS
HLS
HEALIUS ORDINARY
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 28 Aug | — | — |
| 27 Aug | — | — |
| 26 Aug | — | — |
| 25 Aug | 8.81% | — |
| 24 Aug | 8.78% | — |
| 21 Aug | 8.88% | — |
| 20 Aug | 9.05% | — |
| 19 Aug | 9.65% | — |
| 18 Aug | 9.58% | — |
| 17 Aug | 10.13% | — |
| 14 Aug | 10.41% | — |
| 13 Aug | 10.31% | — |
Healius (HLS) Short Interest Summary
Healius (HLS) currently has 8.81% of its shares sold short (63.9 million shares, worth approximately $27.8 million), based on ASIC short position data reported on 25 August 2026 (T+4 reporting lag). That makes HLS the #22 most shorted stock on the ASX most shorted list. Short interest in HLS is down 0.77% over the past week and down 1.98% over the past month. HLS is part of the Health Care sector on the ASX.
Recent HLS Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 25 Aug 2026 | 8.81% | 63.9M | $0.43 |
| 24 Aug 2026 | 8.78% | 63.8M | $0.43 |
| 21 Aug 2026 | 8.88% | 64.4M | $0.46 |
| 20 Aug 2026 | 9.05% | 65.7M | $0.47 |
| 19 Aug 2026 | 9.65% | 70.1M | $0.42 |
| 18 Aug 2026 | 9.58% | 69.5M | $0.44 |
| 17 Aug 2026 | 10.13% | 73.5M | $0.46 |
| 14 Aug 2026 | 10.41% | 75.6M | $0.40 |
| 13 Aug 2026 | 10.31% | 74.9M | $0.42 |
| 12 Aug 2026 | 10.41% | 75.6M | $0.42 |
HLS Short Selling — Frequently Asked Questions
What is Healius (HLS)'s current short interest?
Healius (HLS) currently has a short interest of 8.81% of total shares outstanding. This means 8.81% of HLS's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is HLS heavily shorted on the ASX?
HLS has a moderate level of short interest at 8.81%. While below the heavily shorted threshold of 10%, this indicates notable bearish positioning. HLS is currently ranked #22 among the most shorted stocks on the ASX.
What does short interest mean for HLS investors?
Short interest in HLS shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 8.81%, HLS's short interest is at a moderate level. See our short squeeze candidates and days to cover analysis for more context.
Where does this HLS short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for HLS.